Olcegepant (INN,[1] code name BIBN-4096BS) is a calcitonin gene-related peptide receptor antagonist being studied as a potential treatment for migraines.[2]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C38H47Br2N9O5 |
Molar mass | 869.660 g·mol−1 |
3D model (JSmol) |
|
| |
|
A 2013 meta-analysis found olcegepant and telcagepant were effective and safe compared to placebo.[3]